Kasalicky M, Fried M, Peskova M
First Surgical Department, Faculty General Hospital, Charles University, Prague, Czech Republic.
Obes Surg. 1999 Oct;9(5):443-5. doi: 10.1381/096089299765552710.
Bariatric surgery is the only currently available, effective, long-term method for controlling morbid obesity. Gastric banding as one of the possible surgical treatments was repeatedly described during the last 10 years. It is a reversible surgical procedure which is primarily performed laparoscopically.
From 1993 to 1998 at the 1st Surgical Department Faculty General Hospital Charles University in Prague we performed nonadjustable gastric banding laparoscopically in 487 patients with morbid obesity (body mass index [BMI] 34 to 49 kg/m2). There were 429 females and 58 males in this group.
In 487 patients who underwent laparoscopic nonadjustable gastric banding (LNGB): early postoperative complications occurred in 29 cases (5.9%)-swelling of the gastric mucosa at the site of the nonadjustable band. In three cases (0.6%)--gastric perforations, and in two patients (0.4%)--bleeding from gastric ulceration at the site of the band. Swelling was treated conservatively with a nasogastric tube and antisecretory and antiedematic drugs. Bleeding was treated by gastrofibroscopy and gastric perforation by open suture of the lesion. Late complications after LNGB occurred in eight patients (1.7%)--gastritis or esophagitis (but at the site of the band in only two patients [0.4%]), and in 13 patients (2.7%)--small upper pouch dilatation. In 24 cases (4.9%), we discovered slippage of the anterior stomach wall above the band. In three patients (0.6%), the band migrated through the gastric wall in 6-12 months following surgery. In the majority of cases, treatment of these complications was conservative. In eight patients we removed the band by laparoscopy, and in three patients we removed the migrating band from the stomach by open gastrotomy. Other complications have been treated conservatively by correcting the diet, prokinetic drugs, and antisecretory treatment.
According to our long-term results, LNGB by experienced bariatric and laparoscopic surgeons is a viable method with low morbidity. In our 487 patients, there were major complications (necessitating reoperation) in 3.2% and minor complications (treated conservatively) in 10.4%.
减肥手术是目前唯一可行的、有效的长期控制病态肥胖的方法。胃束带术作为一种可能的手术治疗方法,在过去10年中被反复提及。它是一种可逆的手术,主要通过腹腔镜进行。
1993年至1998年,在布拉格查理大学医学院第一外科,我们对487例病态肥胖患者(体重指数[BMI]34至49kg/m²)进行了腹腔镜非可调式胃束带术。该组中有429名女性和58名男性。
在487例行腹腔镜非可调式胃束带术(LNGB)的患者中:术后早期并发症发生29例(5.9%),为非可调束带部位胃黏膜肿胀。3例(0.6%)发生胃穿孔,2例(0.4%)束带部位胃溃疡出血。肿胀采用鼻胃管及抗分泌、消肿药物保守治疗。出血通过胃镜检查治疗,胃穿孔通过病变部位开放缝合治疗。LNGB术后晚期并发症发生在8例患者(1.7%)——胃炎或食管炎(但仅2例患者[0.4%]发生在束带部位),13例患者(2.7%)——上小袋扩张。24例(4.9%)发现束带上方胃前壁滑脱。3例患者(0.6%)术后6至12个月束带穿过胃壁。在大多数情况下,这些并发症的治疗是保守的。8例患者通过腹腔镜取出束带,3例患者通过开腹胃切开术从胃中取出移位的束带。其他并发症通过调整饮食、促动力药物和抗分泌治疗进行保守治疗。
根据我们的长期结果,由经验丰富的减肥和腹腔镜外科医生进行的LNGB是一种发病率低的可行方法。在我们的487例患者中,严重并发症(需要再次手术)发生率为3.2%,轻微并发症(保守治疗)发生率为10.4%。